A Chinese study published in 2001 used the molecular biological technique restriction fragment length polymorphism to analyze the differences in DNA sequence between 23 A. gallica specimens collected from the Northern Hemisphere.
Recombinant Variants and Potential Recombinant Regions: When PCR product of multiple larvae at the trochophore stage was cloned, 6 recombinant variants were identified in about 200 randomly selected colonies with PCR-RFLP technique (restriction enzymes Hae III and Mbo I).
To this end, we have used a rapid molecular technique, restriction site mutation (RSM), to detect low-frequency mutations in the p53 tumour suppressor gene in premalignant Barrett's tissues of cancer-free patients.
However, equal flow Re and equal flow velocity techniques impose restrictions on the flow conditions and the flow passage configuration.
Each sample was analyzed by a non-radioactive single-stranded conformational polymorphism (SSCP) analysis technique and restriction enzyme digestion.
In addition to the above data types, advances in molecular biology have made it possible to identify different bacterium fingerprints with the technique of restriction fragment length polymorphism (RFLP) and polymorphic GC-rich repetitive-sequence (PGRS) methodologies [13], [14].
The first genome-wide study of DNA methylation in TGCT used the technique of restriction landmark genome scanning (Smiraglia et al, 2002).
39 40 The technique of restriction to a subset of survivors or to more comparable groups is a standard approach in epidemiology but one that is sometimes overlooked or intentionally avoided in favor of a larger sample size.
In Brassica napus, RRLs were constructed for two parents and 91 of their doubled haploid (DH) progenies using the ddRADseq technique, and restriction fragments in the size range of 141 420 bp were chosen to represent the reduced genome and to allow multiplex sequencing to be conducted [ 21].
In this paper, we present a relatively simple molecular technique called restriction site mutation (RSM) (Jenkins et al, 1999, 2001a, 2001b) and assess its ability to detect early p53 mutations in premalignant Barrett's tissues from patients without clinically detectable adenocarcinoma.
